Sherbrooke Park Advisers LLC Acadia Pharmaceuticals Inc Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 22,638 shares of ACAD stock, worth $330,514. This represents 0.13% of its overall portfolio holdings.
Number of Shares
22,638
Previous 18,466
22.59%
Holding current value
$330,514
Previous $284 Million
46.27%
% of portfolio
0.13%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding ACAD
# of Institutions
334Shares Held
167MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$626 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$176 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$127 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$107 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.36B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...